These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
200 related items for PubMed ID: 10790764
21. Helicobacter pylori infection and liver diseases: Epidemiology and insights into pathogenesis. Okushin K, Tsutsumi T, Ikeuchi K, Kado A, Enooku K, Fujinaga H, Moriya K, Yotsuyanagi H, Koike K. World J Gastroenterol; 2018 Aug 28; 24(32):3617-3625. PubMed ID: 30166857 [Abstract] [Full Text] [Related]
22. Procuration and identification of bacteria in paraffin-embedded liver tissues of hepatocellular carcinoma by laser-assisted microdissection technique. Tian XF, Fan XG, Zhang Y, Huang Y, Dai H, Ying RS. APMIS; 2008 Jan 28; 116(1):10-5. PubMed ID: 18254774 [Abstract] [Full Text] [Related]
23. Potential role of Helicobacter pylori in hepatocarcinogenesis. Ito K, Nakamura M, Toda G, Negishi M, Torii A, Ohno T. Int J Mol Med; 2004 Feb 28; 13(2):221-7. PubMed ID: 14719127 [Abstract] [Full Text] [Related]
24. Histological and histochemical alterations in liver of chronic hepatitis C patients with Helicobacter pylori infection. Sakr SA, Badrah GA, Sheir RA. Biomed Pharmacother; 2013 Jun 28; 67(5):367-74. PubMed ID: 23659901 [Abstract] [Full Text] [Related]
25. Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver. Ward JM, Benveniste RE, Fox CH, Battles JK, Gonda MA, Tully JG. Am J Pathol; 1996 Feb 28; 148(2):509-17. PubMed ID: 8579113 [Abstract] [Full Text] [Related]
26. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. J Gastroenterol Hepatol; 2007 Jul 28; 22(7):1104-11. PubMed ID: 17559381 [Abstract] [Full Text] [Related]
27. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. Kowalski M. J Physiol Pharmacol; 2001 Aug 28; 52(1 Suppl 1):3-31. PubMed ID: 11795863 [Abstract] [Full Text] [Related]
28. Helicobacter species and liver diseases: association or causation? Pellicano R, Ménard A, Rizzetto M, Mégraud F. Lancet Infect Dis; 2008 Apr 28; 8(4):254-60. PubMed ID: 18353266 [Abstract] [Full Text] [Related]
32. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients. Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen E, European Concerted Action on Viral Hepatitis (EUROHEP). Am J Gastroenterol; 2002 Nov 28; 97(11):2886-95. PubMed ID: 12425564 [Abstract] [Full Text] [Related]
37. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease. Jung SW, Lee SW, Hyun JJ, Kim DI, Koo JS, Yim HJ, Park JJ, Lee HS, Chun HJ, Um SH, Choi JH, Kim CD, Ryu HS. Dig Liver Dis; 2009 Feb 28; 41(2):134-40. PubMed ID: 18436489 [Abstract] [Full Text] [Related]
38. Helicobacter spp. other than Helicobacter pylori. Okoli AS, Menard A, Mendz GL. Helicobacter; 2009 Sep 28; 14 Suppl 1():69-74. PubMed ID: 19712171 [Abstract] [Full Text] [Related]
39. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus. Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K. Scand J Gastroenterol; 2008 Sep 28; 43(7):849-56. PubMed ID: 18584524 [Abstract] [Full Text] [Related]
40. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Ward JM, Anver MR, Haines DC, Benveniste RE. Am J Pathol; 1994 Oct 28; 145(4):959-68. PubMed ID: 7943185 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]